Filing Details
- Accession Number:
- 0001127602-10-022494
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-09-03 16:07:31
- Reporting Period:
- 2010-09-01
- Filing Date:
- 2010-09-03
- Accepted Time:
- 2010-09-03 16:07:31
- Original Submission Date:
- 2010-09-02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874663 | Alkermes Inc | ALKS | Pharmaceutical Preparations (2834) | 232472830 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236440 | E Floyd Bloom | 852 Winter St. Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-09-01 | 5,000 | $13.40 | 145,375 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This amended Form 4 is being filed to reflect that the range of sale prices was $13.33 to $13.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.